---
title: "HANMA TECHNOLOGY: In the first three quarters, net profit turned from loss to profit year-on-year, and the transformation of products and business to new energy has basically been achieved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263060393.md"
description: "HANMA TECHNOLOGY: In the first three quarters, net profit turned from loss to profit year-on-year, and the transformation of products and business to new energy has basically been achieved"
datetime: "2025-10-28T10:37:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263060393.md)
  - [en](https://longbridge.com/en/news/263060393.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263060393.md)
---

# HANMA TECHNOLOGY: In the first three quarters, net profit turned from loss to profit year-on-year, and the transformation of products and business to new energy has basically been achieved

HANMA TECHNOLOGY released its third quarter report for 2025, with third quarter revenue of 1.607 billion yuan, a year-on-year increase of 35.74%; the net profit attributable to shareholders of the listed company was 12.9044 million yuan, turning from loss to profit year-on-year. In the first three quarters, the operating revenue reached 4.455 billion yuan, a year-on-year increase of 44.54%; the net profit attributable to shareholders of the listed company was 40.6326 million yuan, turning from loss to profit year-on-year. The performance change is mainly due to the increase in product sales, especially the sales of new energy heavy-duty trucks, which increased by 114.98% year-on-year, and the revenue from new energy business reached 3.452 billion yuan, a year-on-year increase of 80.09%. The company has basically achieved the transformation of its products and business to new energy

### Related Stocks

- [600375.CN](https://longbridge.com/en/quote/600375.CN.md)

## Related News & Research

- [Strix Discloses Trust-Led Share Tender by Non-Executive Director](https://longbridge.com/en/news/286884952.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Indonesia’s investment app Pluang raises $10M, expands into equities marketGrows**](https://longbridge.com/en/news/286855201.md)
- [08:31 ETCollege Essay Advisors Introduces a More Personalized AI Platform to Help Students Go from a Blank Page to a Standout Essay](https://longbridge.com/en/news/286771590.md)
- [First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial](https://longbridge.com/en/news/286888745.md)